ArticleInternational journal of hematology2018

Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.

Hiroki Hosoi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.